Celularity Inc.
NASDAQ:CELU
2.1 (USD) • At close May 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 54.22 | 22.771 | 17.975 | 21.335 | 14.278 | 21.147 | 17.554 |
| Cost of Revenue
| 8.893 | 16.016 | 19.665 | 9.653 | 4.932 | 6.324 | 6.555 |
| Gross Profit
| 45.327 | 6.755 | -1.69 | 11.682 | 9.346 | 14.823 | 10.999 |
| Gross Profit Ratio
| 0.836 | 0.297 | -0.094 | 0.548 | 0.655 | 0.701 | 0.627 |
| Reseach & Development Expenses
| 17.386 | 30.465 | 78.363 | 88.353 | 52.707 | 46.051 | 29.063 |
| General & Administrative Expenses
| 0 | 50.532 | 65.858 | 71.089 | 30.572 | 0.564 | 0 |
| Selling & Marketing Expenses
| 0 | 0.044 | 0.163 | 0.252 | 0.764 | 1.158 | 0 |
| SG&A
| 58.643 | 50.576 | 66.021 | 71.341 | 31.336 | 1.684 | 0.001 |
| Other Expenses
| 7.656 | 118.001 | 2.193 | 50.753 | 3.394 | 0 | 0 |
| Operating Expenses
| 83.685 | 199.042 | 146.577 | 159.694 | 87.437 | 1.684 | 0.001 |
| Operating Income
| -38.358 | -192.287 | -25.6 | -148.012 | -78.091 | -1.684 | -0.001 |
| Operating Income Ratio
| -0.707 | -8.444 | -1.424 | -6.938 | -5.469 | -0.08 | -0 |
| Total Other Income Expenses Net
| -19.534 | -3.998 | 39.805 | 8.961 | -61.008 | 7.111 | 0 |
| Income Before Tax
| -57.892 | -196.285 | 14.205 | -100.098 | -212.933 | 6.547 | -0.001 |
| Income Before Tax Ratio
| -1.068 | -8.62 | 0.79 | -4.692 | -14.913 | 0.31 | -0 |
| Income Tax Expense
| 0 | 0.01 | 0.013 | 0.02 | -4.7 | 0.668 | 21.302 |
| Net Income
| -57.892 | -196.295 | 14.192 | -100.118 | -208.233 | 5.879 | -0.001 |
| Net Income Ratio
| -1.068 | -8.62 | 0.79 | -4.693 | -14.584 | 0.278 | -0 |
| EPS
| -2.64 | -11.02 | 1.01 | -8.04 | -22.67 | 2.46 | 0 |
| EPS Diluted
| -2.64 | -11.02 | 0.9 | -8.08 | -22.67 | 2.46 | 0 |
| EBITDA
| -38.358 | -183.946 | 23.582 | -88.11 | -202.405 | -1.684 | -0.001 |
| EBITDA Ratio
| -0.707 | -8.078 | 1.312 | -4.13 | -14.176 | -0.08 | -0 |